Nijmegen/Amsterdam, May 14 2016 RedMedTech Ventures funding enables further development of cyclodextrines. Sanquin Blood Supply Foundation and Okklo Life Sciences BV extend their cardiovascular program. Okklo Life Sciences BV and Sanquin Blood Supply Foundation (Amsterdam) announced today that they are going to expand their research and licensing agreement. Funding from RedMedTech Ventures allows the …